Friday, September 18, 2026
730 articles scanned · 12 high-signal
Washington is tightening the economics of VBC: CMS is expanding care-access models while auditors, rating bodies and drug-pricing officials raise the cost of weak documentation, thin quality performance and opaque rebate strategy.